Verastem | VSTM - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
AbbVie USD 5.57B 2.9B 2026-03
Alaunos Therapeutics USD -7.84M 633K 2023-12
AstraZeneca USD 3.91B 1.28B 2026-03
Curis USD 19.36M 33.34M 2025-12
Cytokinetics USD -206.03M 23M 2026-03
Gilead Sciences USD 2.08B 1.56B 2025-12
Incyte USD 343.6M 46.34M 2026-03
Laboratory Of America USD 8.73B 8.54B 2026-03
Novartis USD 3.84B 802M 2026-03
Pfizer USD 5.18B 6.82B 2026-03
Roche Holding CHF 4.79B 3.01B 2025-06
TG Therapeutics USD 20.36M 24.73M 2026-03
Verastem USD -32.92M 944K 2025-12